FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/103206 [Registered on: 06/02/2026] Trial Registered Prospectively
Last Modified On: 06/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   Factors Affecting Adherence to Medication in Children and Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) 
Scientific Title of Study   Factors affecting adherence to pharmacotherapy in children and adolescents with Attention Deficit Hyperactivity Disorder – a cross-sectional descriptive study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Satya Rama Vikramaditya Tennety 
Designation  Post Graduate Student 
Affiliation  Jawaharlal Nehru Medical College 
Address  OPD No. 15, 1st Floor, KLES Dr. Prabhakar Kore Charitable Hospital and Research center, Nehru Nagar, Belagavi,

Belgaum
KARNATAKA
590010
India 
Phone  7032557647  
Fax    
Email  aditya1080@yahoo.co.in  
 
Details of Contact Person
Scientific Query
 
Name  Satya Rama Vikramaditya Tennety 
Designation  Post Graduate Student 
Affiliation  Jawaharlal Nehru Medical College 
Address  OPD No. 15, 1st Floor, KLES Dr. Prabhakar Kore Charitable Hospital and Research center, Jawaharlal Nehru Medical College, KLE University, Nehru Nagar, Belagavi

Belgaum
KARNATAKA
590010
India 
Phone  7032557647  
Fax    
Email  aditya1080@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  SATYA RAMA VIKRAMADITYA TENNETY 
Designation  POST GRADUATE STUDENT  
Affiliation  JAWAHARLAL NEHRU MEDICAL COLLEGE 
Address  JAWAHARLAL NEHRU MEDICAL COLLEGE, KLE UNIVERSITY, NEHRU NAGAR, BELAGAVI


KARNATAKA
590010
India 
Phone  7032557647  
Fax    
Email  aditya1080@yahoo.co.in  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Satya Rama Vikramaditya Tennety 
Address  001, First Floor, Om Home, Shivabasava Nagara, Nehru Nagar, Belagavi, 590010, Karnataka 
Type of Sponsor  Other [Principal Investigator] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sandeep Patil  KLES Dr. Prabhakar Kore Charitable Hospital And Research Center  OPD No. 15, First Floor KLES DR. Prabhakar Kore Charitable Hospital and Research Center, Nehru Nagar, Belagavi, 590010
Belgaum
KARNATAKA 
7353201136

sandeep04m1108@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
JNMC INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F902||Attention-deficit hyperactivity disorder, combined type,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  6.00 Year(s)
Age To  17.00 Year(s)
Gender  Both 
Details  Children and adolescents diagnosed with Attention Deficit Hyperactivity Disorder defined by Diagnostic and Statistical Manual for Mental Disorders 5 Text Revision criteria.

Children whose parents or guardians can give informed consent.
 
 
ExclusionCriteria 
Details  •Children and adolescents with comorbid medical and neurological conditions.

•Children and adolescents diagnosed with Intellectual Development Disorder
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To estimate the proportion of participants adherent to medication.   1 YEAR 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the effect of prescribing practices on adherence to medications in ADHD.  1 YEAR 
To assess factors influencing adherence to medication  1 YEAR 
 
Target Sample Size   Total Sample Size="89"
Sample Size from India="89" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Attention Deficit Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder of childhood and adolescence, for which pharmacological treatment remains a cornerstone of management. Despite proven efficacy, suboptimal medication adherence is frequently observed, leading to poor clinical outcomes. This study aims at understanding the factors affecting adherence to pharmacotherapy so they can be applied by clinicians to strategize treatment plans for their patients. 
Close